Instruments for combined robotic surgery
The robotic laparoscopic surgical instrument with a 6-degree-of-freedom wrist and ablation probe addresses the trauma of percutaneous modalities by enabling precise, minimally invasive treatment of secondary metastases and lymph nodes, reducing complications.
Patent Information
- Application Number
- PCT/IB2026/054665
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-14
- Filing Date
- 2026-05-11
- Publication Date
- 2026-11-19
AI Technical Summary
Robotic laparoscopic surgical procedures for treating secondary metastases and lymphatic systems in cancer therapies often require additional percutaneous modalities, causing patient trauma and complications like lymphoedema.
A robotic laparoscopic surgical instrument with a 6-degree-of-freedom wrist and ablation probe, integrated with a robotic system, allows for precise application of ablation energy to targets within the body, including lymph nodes, minimizing trauma and maintaining lymphatic function.
The system enables minimally invasive, precise ablation of secondary metastases and lymph nodes, reducing patient trauma and the risk of lymphoedema by maintaining lymphatic system integrity.
Smart Images

Figure IB2026054665_19112026_PF_FP_ABST
Abstract
Description
PATENT APPLICATION Attorney Ref. No. A0013437W001INSTRUMENTS FOR COMBINED ROBOTIC SURGERYCROSS-REFERENCE TO RELATED APPLICATION
[0001] This application claims the benefit of U.S. Provisional Patent Application Serial No. 63 / 805,838, filed May 14, 2025, the entire content of which is incorporated herein by reference.BACKGROUNDTechnical Field
[0002] This disclosure relates to the field of robotic surgery, and in particular, the combination of ablation modalities with robotic surgical navigation for primary, secondary, and lymphatic therapies.Description of Related Art
[0003] Robotic systems have been developed enabling a wide variety of laparoscopic surgical procedures. Robotic laparoscopic surgical procedures are significantly less traumatic for the patient than traditional open surgeries. Further robotic laparoscopic surgical procedures provide benefits over manual laparoscopic procedures by increasing the stability of surgical instruments and enabling robotic guidance to benefit directly from preprocedural imaging. By registering preprocedural images and 3D models derived from the preprocedural imaging a variety of guidance may be presented in a user interface for the surgeon to better understand the location of instruments within the patient, the locations of tumors or lesions in the organs, and generally provide better information for the surgeon to perform the procedure.
[0004] In the area of cancer therapies, robotic surgical resections are now relatively common. Robotic surgical resections (e.g., of the liver) are typically directed at primary metastases. That is, they are directed at addressing the largest or most troubling tumor or lesion, while often relying on other therapeutic modalities to address secondary metastases. As an example, resection of primary metastases may be coupled with microwave or cryoablation of secondary metastases. However, these modalities for treating the secondary metastases are typically percutaneous modalities, thus subjecting the patient to additional trauma in the procedure.PATENT APPLICATION Attorney Ref. No. A0013437W001
[0005] While these procedures are beneficial to the patients, improvements are always desirable. Improvements enabling more effective and accurate robotic laparoscopic procedures are desirable.SUMMARY
[0006] One aspect of the disclosure is directed to a robotic laparoscopic surgical instrument including a shaft configured to be received in a trocar; a wrist at a distal end of the shaft. The instrument also includes an ablation probe extending from the wrist, the ablation probe connectable to an energy source to apply ablation energy via the ablation probe to a target. Other embodiments of this aspect include corresponding computer systems, apparatus, and computer programs recorded on one or more computer storage devices, each configured to perform the actions of the methods.
[0007] Implementations may include one or more of the following features. The robotic laparoscopic surgical instrument where the wrist has 6 degrees of freedom. The shaft is configured to be received by a robotic arm. The ablation probe is selected from the group including a cryogenic ablation probe, a microwave ablation probe, a radio-frequency ablation probe, a pulsed field ablation probe, a pulsed electrical field ablation probe ablation, an irreversible electroporation ablation probe, a thermal ablation probe, an ultrasound ablation probe, a high-frequency ultrasound ablation probe, a laser ablation probe, a chemical ablation probe and an ethanol ablation probe. The robotic laparoscopic surgical instrument may include a sensor configured to determine a position and orientation of the distal end of the ablation probe. The sensor is an electromagnetic sensor. The sensor is a tunnel magnetoresistance sensor. Implementations of the described techniques may include hardware, a method or process, or computer software on a computer-accessible medium.
[0008] A further aspect of the disclosure is directed to a robotic system including a robotic articulating catheter configured to be received in a trocar, the robotic articulating catheter including a working channel, and a flexible ablation probe configured to be received in the working channel and connectable to an energy source to apply ablation energy via the flexible ablation probe to a target. Other embodiments of this aspect include corresponding computer systems, apparatus, and computer programs recorded on one or more computer storage devices, each configured to perform the actions of the methods.
[0009] Implementations may include one or more of the following features. The robotic system where the articulating catheter is articulable in 5 or 6 degrees of freedom. ThePATENT APPLICATION Attorney Ref. No. A0013437W001articulating catheter is configured to be mounted on and driven by a robotic arm. The robotic system may include a surgical instrument secured to a robotic arm and configured to be inserted into the working channel of the articulating catheter. The surgical instrument includes a working channel configured to receive the flexible ablation probe. The robotic system of any may include a laparoscopic camera configured to observe navigation of the articulating catheter. The flexible ablation is selected from the group may include of a cryogenic ablation probe, a microwave ablation probe, a radio-frequency ablation probe, a pulsed field ablation probe, a pulsed electrical field ablation probe ablation, an irreversible electroporation ablation probe, a thermal ablation probe, an ultrasound ablation probe, a high-frequency ultrasound ablation probe, and a laser ablation probe. The robotic system may include a sensor configured to determine a position and orientation of a distal end of the robotic articulating catheter. The sensor is an electromagnetic sensor. The sensor is a tunnel magnetoresistance sensor. The robotic system may include a computing device including a processor and a memory, the memory storing instructions that when executed by the processor cause the computing device to: detect a position and orientation of the articulating catheter; and display a representation of the articulating catheter in a 3D model. The instructions when executed by the processor cause the computing device to: register the 3D model to a patient. The robotic system may include a magnetic field generator. Implementations of the described techniques may include hardware, a method or process, or computer software on a computer-accessible medium.
[0010] One or more computers can be configured to perform particular operations or actions by virtue of having software, firmware, hardware, or a combination of them installed on the system that in operation causes or cause the system to perform the actions. One or more computer programs can be configured to perform particular operations or actions by virtue of including instructions that, when executed by data processing apparatus, cause the apparatus to perform the actions.BRIEF DESCRIPTION OF THE DRAWINGS
[0011] Various aspects and embodiments of the disclosure are described hereinbelow with references to the drawings, wherein:
[0012] FIG. 1 is a schematic view of a robotic laparoscopic surgical system in accordance with the disclosure;PATENT APPLICATION Attorney Ref. No. A0013437W001
[0013] FIG. 2 is a schematic view of an ablation end effector of a robotic laparoscopic surgical system in accordance with the disclosure;
[0014] FIG. 3 is a schematic view of an articulating catheter and alation probe inserted into a target for therapy; and
[0015] FIG. 4 is a schematic diagram of a computing system in accordance with the disclosure.DETAILED DESCRIPTION
[0016] An aspect of the disclosure is directed to a robotic laparoscopic end effector including an ablation probe. The robotic laparoscopic end effector is insertable through the trocars providing access to the abdomen or thoracic cavity of the patient. The ablation probe mounted on a distal end of the robotic laparoscopic end effector. The ablation probe is shorter than its percutaneous counterparts, thus increasing its maneuverability within abdominal or thoracic cavity of the patient. The laparoscopic end effector has six degrees of freedom (6 DOF) enabling accurate manipulation and placement of the ablation probe in a tumor or lesion to receive therapy. The ablation probe is connected through the laparoscopic end effector to an energy source (e.g., a microwave generator, a cryo-fluid source, etc.) and control for the energy source is enabled via a user interface used by the surgeon to manipulate and navigate the robotic laparoscopic end effector and other tools of the robotic system.
[0017] A further aspect of the disclosure is directed to an articulating catheter connected to a robotic arm. The articulating catheter is advanceable through a trocar to cavities of the body (e.g., thoracic or abdominal). A flexible ablation probe is advanced through the articulating catheter and into the tumor or lesion. With the ablation probe so placed, the articulating catheter may be retracted a distance from ablation probe to remove the articulating catheter from any field (RF or microwave) generated by the ablation probe. These and other aspects of the disclosure are described in greater detail below.
[0018] FIG. 1 depicts a laparoscopic surgical robotic system 10 including a control tower 20, which is connected to all of the components of the laparoscopic surgical robotic system 10 including a surgeon console 30 and one or more mobile carts 60. Each of the mobile carts 60 includes a robotic arm 40 and a surgical instrument 50 removably coupled to the mobile cart 60 via the robotic arm 40. The robotic system 10 may include any number of mobile carts 60 and / or robotic arms 40.PATENT APPLICATION Attorney Ref. No. A0013437W001
[0019] The surgical instrument 50 is configured for use during minimally invasive surgical procedures (e.g., laparoscopic). The surgical instrument 50 include an end effector 49 such as an electrosurgical forceps configured to seal tissue by compressing tissue between jaw members and applying electrosurgical current thereto, a surgical stapler including a pair of jaws configured to grasp and clamp tissue while deploying a plurality of tissue fasteners, e.g., staples, and cutting stapled tissue, a surgical clip applier including a pair of jaws configured apply a surgical clip onto tissue or other end effectors 49 without departing from the scope of the disclosure. Further, as described in greater detail below, the end effector may be an ablation probe.
[0020] One of the surgical instruments 50 may be a laparoscopic camera 51 configured to capture video of the surgical site. The laparoscopic camera 51 may be a stereoscopic endoscope configured to capture two side-by-side (i.e., left and right) images of the surgical site to produce a video stream of the surgical scene. The laparoscopic camera 51 is coupled to an image processing device, which may be disposed within the control tower 20. The image processing device may be any computing device configured to receive the image feed from the laparoscopic camera 51 and output the processed images or video stream.
[0021] The surgeon console 30 includes a first screen 32, which displays a video feed of the surgical site provided by camera 51 of the surgical instrument 50 disposed on the robotic arm 40, and a second screen 34, which displays a user interface for controlling the surgical robotic system 10. The first screen 32 and second screen 34 may be touchscreens allowing for displaying various graphical user inputs.
[0022] The surgeon console 30 also includes a plurality of user interface devices, such as foot pedals 36 and a pair of hand controllers 38a and 38b which are used by a user to remotely control robotic arms 40. The surgeon console further includes an armrest 33 used to support clinician's arms while operating the hand controllers 38a and 38b.
[0023] The control tower 20 includes a screen 23, which may be a touchscreen, and outputs on the graphical user interfaces (GUIs). The control tower 20 also acts as an interface between the surgeon console 30 and one or more robotic arms 40. In particular, the control tower 20 is configured to control the robotic arms 40, such as to move the robotic arms 40 and the corresponding surgical instrument 50, based on a set of programmable instructions and / or input commands from the surgeon console 30, in such a way that robotic arms 40 and the surgical instrument 50 execute a desired movement sequence in responsePATENT APPLICATION Attorney Ref. No. A0013437W001to input from the foot pedals 36 and the hand controllers 38a and 38b. The foot pedals 36 may be used to enable and lock the hand controllers 38a and 38b, repositioning camera movement and electrosurgical activation / deactivation. In particular, the foot pedals 36 may be used to perform a clutching action on the hand controllers 38a and 38b. Clutching is initiated by pressing one of the foot pedals 36, which disconnects (i.e., prevents movement inputs) the hand controllers 38a and / or 38b from the robotic arm 40 and corresponding instrument 50 or camera 51 attached thereto. This allows the user to reposition the hand controllers 38a and 38b without moving the robotic arm(s) 40 and the instrument 50 and / or laparoscopic camera 51. This is useful when reaching control boundaries of the surgical space.
[0024] Each of the control tower 20, the surgeon console 30, and the robotic arm 40 includes a respective computer 21, 31, 41. The computers 21, 31, 41 are interconnected to each other using any suitable communication network based on wired or wireless communication protocols. The term “network,” whether plural or singular, as used herein, denotes a data network, including, but not limited to, the Internet, Intranet, a wide area network, or a local area network, and without limitation as to the full scope of the definition of communication networks as encompassed by the present disclosure. Suitable protocols include, but are not limited to, transmission control protocol / internet protocol (TCP / IP), datagram protocol / internet protocol (UDP / IP), and / or datagram congestion control protocol (DC). Wireless communication may be achieved via one or more wireless configurations, e.g., radio frequency, optical, Wi-Fi, Bluetooth (an open wireless protocol for exchanging data over short distances, using short length radio waves, from fixed and mobile devices, creating personal area networks (PANs), ZigBee® (a specification for a suite of high level communication protocols using small, low-power digital radios based on the IEEE 122.15.4-1203 standard for wireless personal area networks (WPANs)).
[0025] The computers 21, 31, 41 may include any suitable processor (not shown) operably connected to a memory (not shown), which may include one or more of volatile, non-volatile, magnetic, optical, or electrical media, such as read-only memory (ROM), random access memory (RAM), electrically-erasable programmable ROM (EEPROM), non-volatile RAM (NVRAM), or flash memory. The processor may be any suitable processor (e.g., control circuit) adapted to perform the operations, calculations, and / or set of instructions described in the present disclosure including, but not limited to, a hardwarePATENT APPLICATION Attorney Ref. No. A0013437W001processor, a field programmable gate array (FPGA), a digital signal processor (DSP), a central processing unit (CPU), a microprocessor, and combinations thereof. Those skilled in the art will appreciate that the processor may be substituted for by using any logic processor (e.g., control circuit) adapted to execute algorithms, calculations, and / or set of instructions described herein.
[0026] FIG. 2 depicts a distal end of a surgical instrument 50. The surgical instrument 50 includes shaft 100 terminating at a 6 DOF articulating wrist 102. The wrist 102 enables 6 DOF for the movement of the end effector 49, here ablation probe 104. In practice, the surgical instrument 50 is inserted via a trocar into the patient’s body cavity (e.g., abdominal cavity). The body cavity is insufflated to increase the volume in which the surgical instrument 50 can manipulated within the patient.
[0027] The ablation probe 104 is connected to an energy source 106 that may be carried on one of the carts 60. The energy source connects to one of the screens 32, 34 and may be controlled by one of the computers 21, 31, 41. In this manner, control of the ablation probe 104 is brought within the control systems of the laparoscopic surgical robotic system 10. As a result, control of the application of energy to tissue via the ablation probe 104 is within the same user interfaces employed for control of the robotic arms 40, and the surgical instruments 50.
[0028] As noted above, some patients will present multiple metastases, however, for a variety of reasons, only the primary metastasis will be the subject of the resection. This may be due to the proximity of the secondary metastasis being near a large blood vessel or biliary duct, preventing surgical resection, or limitations on the sufficiency of the organ if both metastases were resected. Still further, the secondary metastases may be relatively small compared to the volume of tissue that would be required to be resected, making the resection undesirable. In such instances, complimentary therapy may be employed. Previously the complimentary therapy was limited to systemic therapies such as chemotherapy or percutaneous ablation, both of these therapies have drawbacks for patients already undergoing surgery. While described herein above as directed at secondary metastases, the disclosure is not so limited and devices and systems described herein may be employed to treat primary metastases without departing from the scope of the disclosure.
[0029] In accordance with the disclosure, with the trocars in place on the patient, one of the robotic arms 40 can be loaded with a surgical instrument 50 including the ablation probePATENT APPLICATION Attorney Ref. No. A0013437W001104 as the end effector 49. The ablation probe 104 can be inserted through the trocar, and under direct visualization of the laparoscopic camera 51 (on a separate surgical instrument 50) the ablation probe 104 can be advanced to the secondary metastases, and therapy applied. Manipulation of the surgical instrument 50 and ablation probe 104 may be guided or adjusted by a digital twin as well as informed by pre-procedure and intra-procedure images (e.g., computed tomography (CT), cone-beam CT (CBCT), magnetic resonance imaging (MRI), fluoroscopy, or ultrasound). Like other laparoscopic procedures, the interface between the patient and the trocar enables some angulation of the surgical instrument relying in part on the flexibility of the patient’s tissue. In addition, the wrist 102 allows for changes in angulation and orientation of just the ablation probe 104. By adjusting the angulation of the robotic arm 40 and the wrist 102 the ablation probe can be inserted into the tumor or lesion.
[0030] The ablation probe 104, may employ any ablation energy including without limitation cryogenic, microwave (MW), radio-frequency (RF), pulsed field ablation (PF A), pulsed electrical field (PEF) ablation, irreversible electroporation (IRE), thermal, ultrasound (US), high-frequency ultrasound (HIFU), laser, chemical, ethanol, and others without departing from the scope of the disclosure. Still further, the ablation probe 104 may instead be a targeted therapy application probe (e.g., direct tumoral injection) delivering targeted therapeutics (e.g., drugs, small molecules or nanoparticles) or immune response triggering substances without departing from the scope of the disclosure. In addition, combinations of the therapies (e.g., energy based and drug based) may be undertaken without departing from the scope of the disclosure.
[0031] Where MW energy is employed, the ablation probe 104, though functionally similar to a percutaneous ablation needle (e.g., the EMPRINT™ Percutaneous Antenna), the length of the ablation probe 104 is only about 3-5 cm in length extending from the wrist 102, as opposed to 15, 20, or more cm in length for typical percutaneous ablation needles. The reduced length increases the ability of the ablation probe 104 to be navigated and placed in a target (e.g., tumor or lesion). However, the length of the MW ablation probe 104 must be sufficient to keep the wrist 102 and surgical instrument 50 out of any microwave field generated by the antenna. Other modalities may not require such considerations, for example the only considerations for cryogenic ablation is the ability to navigated within the patient and to successfully reach the desired target within the organ.PATENT APPLICATION Attorney Ref. No. A0013437W001
[0032] Additionally, the systems and methods described herein may be particularly useful in prophylactically treating the lymphatic system. As is known, the lymphatic system, composed of a series of lymph nodes and lymph ducts which help maintain healthy fluid levels, absorb fats, and produce lymphocytes as part of the body’s immune response. As a result, a significant volume of fluid flows through the lymphatic system on a daily basis. As a result of this fluid flow all types of cells, including cancerous cells, traverse the lymphatic system. Unfortunately, this fluid flow can result in the spread of cancerous cells from one portion of the body to another. Thus, in many resection procedures, along with removing a portion of an organ (e.g., the liver) lymph nodes in proximity to the portion of the organ being resected may also be removed.
[0033] Removal of lymph nodes, however, while limiting the potential spread of cancer through the body, is not without its own drawbacks. One such drawback is lymphoedema, the retention of fluids in the extremities of the patient. Lymphoedema is a serious challenge for all patients who have portions of their lymphatic system removed or damaged. Indeed, following removal of lymph nodes or damage to lymph nodes, the downstream lymph nodes may be rendered useless or at least significantly impaired, thus resulting in the lymphoedema.
[0034] In accordance with the disclosure, rather than removing the lymph nodes in proximity to the primary or secondary metastases, following therapy (e.g., resection or ablation) the surgical instrument 50 including the ablation probe 104 and under direct visualization via the laparoscopic camera 51 is navigated to one or more of the lymph nodes in proximity to the organ receiving the primary or secondary therapy. The ablation probe 104 is inserted into the lymph node, and in one aspect of the disclosure, where the ablation probe 104 is a cryogenic ablation probe a series of freeze / thaw cycles are undertaken. By repeatedly freezing the fluid within the lymph node the cell structures of the cells within the fluid are denigrated and destroyed effectively sterilizing of these cancerous cells within the fluid. However, unlike removal of the lymph node, the structure of the lymph node remains intact. As a result, while certain functions of the lymph node (e.g., pumping) may be interrupted or permanently terminated, the lymphatic system remains otherwise intact, allowing for the lymphatic fluid to continue to be transported to lymph nodes further downstream, and limiting the occurrence of lymphoedema as a result of the surgery. Application of therapy to the sentinel node is always desirable but applying therapy toPATENT APPLICATION Attorney Ref. No. A0013437W001multiple lymph nodes both upstream and downstream of the sentinel node may also be desirable, especially as the patency of the lymph nodes is not adversely affected and the drainage functions of the lymphatic system remain intact.
[0035] Additional benefits of the ablation probe 104 mounted to the robotically driven surgical instrument 50 is that the ablation probe 104 is locked into position by the robotic arm 40, thus once inserted into the target the ablation probe 104 is locked in the target. Further, movements of the robotic arm 40 and therewith the surgical instrument 50 and ablation probe 104 can be gated to the patient’s respiration and cardiac cycles, to minimize the effect of movement of the organs or lymph nodes caused by these cycles. Still further, if movement of the organ or lymph node is detected, the surgeon acting in accordance with the direct visualization can compensate by moving the robotic arm 40, surgical instrument 50 or wrist 102, accordingly. In addition, under direct visualization, when a lymph node or other target is identified in the laparoscopic images, one or more applications operating on computer 21, 31, or 41 can triangulate a location in space of that lymph node or target in space relative to both the laparoscopic camera 51 and the ablation probe 104. This allows the robotic system 10 to autonomously advance the ablation probe 104 to and into the lymph node or target and then hold the ablation probe in that location during the application of the therapy.
[0036] Though described herein above with respect to an ablation probe 104 connected at a wrist 102 of a surgical instrument 50 mounted on a robotic arm 40, this disclosure is not so limited. Recently there have been significant developments in the production of articulating catheters that can be employed in laparoscopic surgery. FIG. 3 depicts an articulating catheter 202 inserted into a trocar 204 that has been inserted into a patient for laparoscopic surgery. The articulating catheter 202 is mounted on the robotic arm 40 and controlled via the laparoscopic surgical robotic system 10. The articulating catheter 202 may have 5 DOF or 6 DOF. As such, a surgeon guides the movements of the articulating catheter 202, both advancement and angulation via the robotic arm 40 and articulation of the articulating catheter 202. As can be seen in FIG. 3, the articulating catheter 202 may have multiple points of articulation such that multiple bends may be achieved in the articulation catheter 202. A seal (not shown) on the trocar 204 prevents or limits the escape of insufflation gasses from the abdominal or thoracic cavity. As an example, the articulating catheter 202 may be a FORTIMEDIX articulating catheter employing tendons and nestedPATENT APPLICATION Attorney Ref. No. A0013437W001laser cut tubes having 6 DOF articulation capabilities. Alternatively, the articulating catheter 202 may be a more traditional pull-wire manipulated catheter without departing from the scope of the disclosure.
[0037] Regardless of the articulating catheter 202 employed, in accordance with the disclosure, following insertion of the articulating catheter 202 through the trocar 204 the articulating catheter 202 is advanced under direct visualization from the laparoscopic camera 51. The articulating catheter 202 is navigation (either manually or autonomously) to a desired location within the patient. The opening 208 at the distal end of the articulating catheter 202 is aligned with the target (e.g., tumor or lymph node). With the articulating catheter 202 aligned with the target the flexible ablation probe 206 is inserted into the articulating catheter 202. The articulation of the articulation catheter 202 may be controlled by one or more applications on computers 21, 31, 41 to prevent an articulation of such a tight radius that the ablation probe 206 cannot pass through the articulation catheter 202. Advancement of the flexible ablation probe 206 (a distal portion of which may be rigid) form the articulating catheter 202 causes the articulating catheter 202 to arrive at the organ (or lymph node) and be inserted into the target. With ablation probe 206 in the target, ablation energy (therapy) is applied to the target.
[0038] In some instances, for example if the ablation probe 206 is a MW ablation probe, as a result, prior to the application of MW energy to the target, the articulating catheter 202 may need to be retracted a distance (e.g., 3-5 cm) to remove the articulating catheter 202 from the MW energy field and prevent or minimize energy coupling with the articulating catheter 202.
[0039] The retraction of the articulating catheter 202 may be an autonomous retraction by the laparoscopic surgical robotic system 10. As an example, during the navigation to the location at which the ablation probe 206 is to be inserted or extended from the articulating catheter 202, the laparoscopic surgical robotic system 10 collects a series of data points (e.g., breadcrumbs) which are locations in space. As a result, to retract the articulating catheter 202, the laparoscopic surgical robotic system 10 may simply follow the breadcrumbs in reverse a desired distance. The retraction of the articulating catheter 202 must maintain the opening 208 orthogonal to the ablation probe 206. The maintenance of orthogonality limits the application of force to the ablation probe 206 from the articulating catheter 202 thatPATENT APPLICATION Attorney Ref. No. A0013437W001might alter the position of the ablation probe 206 within the target or change a therapeutic field generated by the ablation probe 206.
[0040] As a further alternative, and as depicted in FIG. 3, a surgical instrument 50 that is mounted to the robotic arm 40, can include a port 210 connected to a working channel (not shown) within the surgical instrument 50. The working channel allows for the passage of an ablation probe 206 through the surgical instrument 50 and the articulating catheter 202 into which the surgical instrument 50 is at least partially inserted to arrive at the opening 208 for advancement into the target and application of therapy, much in the manner described above. As will be appreciated, the port 210 includes a seal preventing the escape of insufflation gasses from the patient.
[0041] Utilizing the systems and methods described herein, the surgeon is able to leverage the stability and precision of robotic surgery (e.g., resection) under direct laparoscopic visualization in the laparoscopic ablation of a variety of targets within the patient. Robotic laparoscopic ablation reduces the trauma on the patient (e.g., eliminating percutaneous ablation insertions). The systems and methods described herein integrates control of ablation energy sources with the laparoscopic surgical robotic system 10 making the control of these therapies available via one or more of the screens 32, 34 with the execution of applications one or more of the computers 21, 31, 41. The placement of the ablation probe 104, 206 and catheter 202 is robotically controlled (either manually or autonomously) using the features of the laparoscopic surgical robotic system 10. Therapy can be applied to primary metastases, secondary metastases, or lymph nodes in proximity to the primary or secondary metastases. By treating the lymph nodes, particularly with cryogenic ablation, the patency of the lymph nodes and the lymphatic ducts is retained while the fluids therein are treated to kill cancerous cells within. The lymph nodes and the lymphatic ducts at minimum still enable passage of lymphatic fluid and thus limit the development of lymphoedema following the therapy.
[0042] Though described herein generally as performing the resection or primary metastases therapy first, and the secondary and lymphatic therapies second, the disclosure is not so limited. In some instances, the therapies may be performed simultaneously or the lymphatic or secondary metastases may be treated first, or in any order desired by the surgeon.PATENT APPLICATION Attorney Ref. No. A0013437W001
[0043] In accordance with aspects of the disclosure a tracking system may be employed to detect a location of the ablation probe 104, 206 within the patient. The tracking system may be, for example, an electromagnetic (EM) tracking system employing a magnetic field generator placed under the patient and emitting a detectable magnetic field. As will be appreciated other orientations of the antenna may be employed, including above the patient or to the side of the patient and secured to the surgical table on which the patient is placed for the procedure. The magnetic field generator may be comprised of multiple antennae, each emitting a different and individually detectable magnetic field. Each surgical instrument 50 may include one or more magnetic sensors. The magnetic sensors may be air coil sensors which detect the position and orientation of the surgical instrument in 5 DOF, or a tunnel magnetoresistance (TMR) sensor which can detect the position and orientation of the surgical instrument 50 in 6 DOF. Because the length of the ablation probe 104 is known, and the articulation of the wrist 102 is known, the position and orientation of a distal end of the ablation probe 104 can be calculated from the detected position and orientation of the surgical instrument 50.
[0044] In addition to a sensor on the surgical instrument, one or more sensors may also be located on the catheter 202. As will be appreciated, because the catheter is an articulating catheter, its position and orientation within the patient cannot be as easily calculated. To assist in determining the position and orientation of the catheter, and particularly the opening 208 one or more sensors is incorporated on the catheter 202. In one aspect of the disclosure the detected position of the sensors within the patient can be compared to a calculated shape and position of the articulated catheter and a detected position of a sensor on the surgical instrument 50.
[0045] In practice, pre-procedural images of the patient (e.g., MRI or CT images) and 3D models generated from these images can be generated and the targets for therapy identified. Following placement of the laparoscopic ports or trocars 204 a registration process may be undertaken where one or more surgical instruments 50 are driven to positions within the patient that also appear in the pre-procedural images or 3D models. Once the images or 3D model are registered to the patient, movements of the surgical instruments 50, ablation probes 104, 206, and catheter 202 are detected and representations of these tools can be displayed on one of the screens 32, 34 in connection with a navigation application running on one or more of the computers 21, 31, 41 relative to the pre-procedurePATENT APPLICATION Attorney Ref. No. A0013437W001images or 3D model. As a result, targets which may not be visible in the laparoscopic images captured by the laparoscopic camera 51 may nonetheless be navigated to and ablated as described herein above.
[0046] Reference is now made to FIG. 4, which is a schematic diagram of a computing system 300 configured for use with the methods of the disclosure. The computing system may be found in any of computers 21, 31, 41. System 300 may include a workstation 301, and optionally an imaging device 315 (e.g., a fluoroscope, CT imaging device, an ultrasound imaging device, laparoscopic cameras, etc.). In some embodiments, workstation 301 may be coupled with imaging device 315, directly or indirectly, e.g., by wireless communication. Workstation 301 may include a memory 302, a processor 304, a display 306 and an input device 310. Processor or hardware processor 304 may include one or more hardware processors. Workstation 301 may optionally include an output module 312 and a network interface 308. Memory 302 may store an application 318 and image data 314. Application 318 may include instructions executable by processor 304 for executing the methods of the disclosure.
[0047] Application 318 may further include a user interface 316. Image data 314 may include the CT scans, 3D models, fluoroscopic 3D reconstructions, ultrasound images, laparoscopic images and others. Processor 304 may be coupled with memory 302, display 306, input device 310, output module 312, network interface 308 and imaging device 315. Workstation 301 may be a stationary computing device, such as a personal computer or a portable computing device such as a tablet computer, or further be implemented on the computers 21, 31, 41, further, workstation 301 may embed a plurality of computer devices.
[0048] Memory 302 may include any non-transitory computer-readable storage media for storing data and / or software including instructions that are executable by processor 304 and which control the operation of workstation 301 and, in some embodiments, may also control the operation of imaging device 315. In an embodiment, memory 302 may include one or more storage devices such as solid-state storage devices, e.g., flash memory chips. Alternatively, or in addition to the one or more solid-state storage devices, memory 302 may include one or more mass storage devices connected to the processor 304 through a mass storage controller (not shown) and a communications bus (not shown).
[0049] Although the description of computer-readable media contained herein refers to solid-state storage, it should be appreciated by those skilled in the art that computer-readablePATENT APPLICATION Attorney Ref. No. A0013437W001storage media can be any available media that can be accessed by the processor 304. That is, computer readable storage media may include non-transitory, volatile, and non-volatile, removable and non-removable media implemented in any method or technology for storage of information such as computer-readable instructions, data structures, program modules or other data. For example, computer-readable storage media may include RAM, ROM, EPROM, EEPROM, flash memory or other solid-state memory technology, CD-ROM, DVD, Blu-Ray or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices, or any other medium which may be used to store the desired information, and which may be accessed by workstation 301.
[0050] Application 318 may, when executed by processor 304, cause display 306 to present user interface 316. User interface 316 may be configured to present to the user one or more of a three-dimensional (3D) view of a 3D model, a live fluoroscopic images, live ultrasound images, live laparoscopic images, a target view, which corresponds to the 3D model of the target, overlaid on the live images (e.g., CT or fluoroscopic) and other imaging combinations. Still further, in connection with the above descriptions the user interface 316 can be configured to depict any of the aspects of the endoluminal pathway or the laparoscopic surgical plan in the 3D model, deformed 3D model, or the intraprocedural images.
[0051] Network interface 308 may be configured to connect to a network such as a local area network (LAN) consisting of a wired network and / or a wireless network, a wide area network (WAN), a wireless mobile network, a Bluetooth network, and / or the Internet. Network interface 308 may be used to connect between workstation 301 and imaging device 315. Network interface 308 may also be used to receive image data 314. Input device 310 may be any device by which a user may interact with workstation 301, such as, for example, a mouse, keyboard, foot pedal, touch screen, and / or voice interface. Output module 312 may include any connectivity port or bus, such as, for example, parallel ports, serial ports, universal serial busses (USB), or any other similar connectivity port known to those skilled in the art. From the foregoing and with reference to the various figures, those skilled in the art will appreciate that certain modifications can be made to the disclosure without departing from the scope of the disclosure.PATENT APPLICATION Attorney Ref. No. A0013437W001
[0052] EXAMPLES
[0053] Example 1 - A robotic laparoscopic surgical instrument including a shaft configured to be received in a trocar, a wrist at a distal end of the shaft, and an ablation probe extending from the wrist, the ablation probe connectable to an energy source to apply ablation energy via the ablation probe to a target.
[0054] Example 2 - The robotic laparoscopic surgical instrument of example 1, wherein the wrist has six degrees of freedom.
[0055] Example 3 - The robotic laparoscopic surgical instrument of one of the preceding examples claims, wherein the shaft is configured to be received by a robotic arm.
[0056] Example 4 - The robotic laparoscopic surgical instrument of one of the preceding examples, wherein the ablation probe is selected from the group consisting of a cryogenic ablation probe, a microwave ablation probe, a radio-frequency ablation probe, a pulsed field ablation probe, a pulsed electrical field ablation probe ablation, an irreversible electroporation ablation probe, a thermal ablation probe, an ultrasound ablation probe, a high-frequency ultrasound ablation probe, a laser ablation probe, a chemical ablation probe and an ethanol ablation probe.
[0057] Example 5 - The robotic laparoscopic surgical instrument of one of the preceding examples further comprising a sensor configured to determine a position and orientation of the distal end of the ablation probe.
[0058] Example 6 - The robotic laparoscopic surgical instrument of example 5, wherein the sensor is an electromagnetic sensor.
[0059] Example 7 - The robotic laparoscopic surgical instrument of example 5, wherein the sensor is a tunnel magnetoresistance sensor.
[0060] Example 8 - A robotic system including a robotic articulating catheter configured to be received in a trocar, the robotic articulating catheter including a working channel, and a flexible ablation probe configured to be received in the working channel and connectable to an energy source to apply ablation energy via the flexible ablation probe to a target.
[0061] Example 9 - The robotic system of example 8, wherein the articulating catheter is articulable in five- or sic-degrees of freedom.
[0062] Example 10 - The robotic system of one of examples 8-9, wherein the articulating catheter is configured to be mounted on and driven by a robotic arm.PATENT APPLICATION Attorney Ref. No. A0013437W001
[0063] Example 11 - The robotic system of one of examples 8-10, further comprising a surgical instrument secured to a robotic arm and configured to be inserted into the working channel of the articulating catheter.
[0064] Example 12 - The robotic system of example 11, wherein the surgical instrument includes a working channel configured to receive the flexible ablation probe.
[0065] Example 13 - The robotic system of any of examples 8-12, further comprising a laparoscopic camera configured to observe the navigation of the articulating catheter.
[0066] Example 14 - The robotic system of any of examples 8-12, wherein the flexible ablation probe is selected from the group consisting of a cryogenic ablation probe, a microwave ablation probe, a radio-frequency ablation probe, a pulsed field ablation probe, a pulsed electrical field ablation probe ablation, an irreversible electroporation ablation probe, a thermal ablation probe, an ultrasound ablation probe, a high-frequency ultrasound ablation probe, and a laser ablation probe.
[0067] Example 15 - The robotic system of one of examples 8-14, further comprising a sensor configured to determine a position and orientation of a distal end of the robotic articulating catheter.
[0068] Example 16 - The robotic system of example 15, wherein the sensor is an electromagnetic sensor.
[0069] Example 17 - The robotic system of example 15, wherein the sensor is a tunnel magnetoresistance sensor.
[0070] Example 18 - The robotic system of one of examples 8-17, further comprising a magnetic field generator.
[0071] Example 19 - The robotic system of one of examples 15-18, further comprising a computing device including a processor and a memory, the memory storing instructions that when executed by the processor cause the computing device to: detect a position and orientation of the articulating catheter; and display a representation of the articulating catheter in a 3D model.
[0072] Example 20 - The robotic system of example 19, wherein the instructions when executed by the processor cause the computing device to register the 3D model to a patient.PATENT APPLICATION Attorney Ref. No. A0013437W001
[0073] Although embodiments have been described in detail with reference to the accompanying drawings for the purpose of illustration and description, it is to be understood that the inventive processes and apparatus are not to be construed as limited. It will be apparent to those of ordinary skill in the art that various modifications to the foregoing embodiments may be made without departing from the scope of the disclosure.
Claims
PATENT APPLICATION Attorney Ref. No. A0013437W001 We claim:
1. A robotic laparoscopic surgical instrument comprising:a shaft configured to be received in a trocar;a wrist at a distal end of the shaft; andan ablation probe extending from the wrist, the ablation probe connectable to an energy source to apply ablation energy via the ablation probe to a target.
2. The robotic laparoscopic surgical instrument of claim 1, wherein the wrist has 6 degrees of freedom.
3. The robotic laparoscopic surgical instrument of one of the preceding claims, wherein the shaft is configured to be received by a robotic arm.
4. The robotic laparoscopic surgical instrument of one of the preceding claims, wherein the ablation probe is selected from the group consisting of a cryogenic ablation probe, a microwave ablation probe, a radio-frequency ablation probe, a pulsed field ablation probe, a pulsed electrical field ablation probe ablation, an irreversible electroporation ablation probe, a thermal ablation probe, an ultrasound ablation probe, a high-frequency ultrasound ablation probe, a laser ablation probe, a chemical ablation probe and an ethanol ablation probe.
5. The robotic laparoscopic surgical instrument of one of the preceding claims further comprising a sensor configured to determine a position and orientation of the distal end of the ablation probe.
6. The robotic laparoscopic surgical instrument of claim 5, wherein the sensor is an electromagnetic sensor.
7. The robotic laparoscopic surgical instrument of claim 5, wherein the sensor is a tunnel magnetoresistance sensor.
8. A robotic system comprising:a robotic articulating catheter configured to be received in a trocar the robotic articulating catheter including a working channel; anda flexible ablation probe configured to be received in the working channel and connectable to an energy source to apply ablation energy via the flexible ablation probe to a target.
9. The robotic system of claim 8, wherein the articulating catheter is articulable in 5 or 6 degrees of freedom.
10. The robotic system of one of claims 8-9, wherein the articulating catheter is configured to be mounted on and driven by a robotic arm.
11. The robotic system of one of claims 8-10, further comprising a surgical instrument secured to a robotic arm and configured to be inserted into the working channel of the articulating catheter.
12. The robotic system of claim 11, wherein the surgical instrument includes a working channel configured to receive the flexible ablation probe.PATENT APPLICATION Attorney Ref. No. A0013437W00113. The robotic system of any of claims 8-12, further comprising a laparoscopic camera configured to observe the navigation of the articulating catheter.
14. The robotic system of any of claims 8-12, wherein the flexible ablation is selected from the group consisting of a cryogenic ablation probe, a microwave ablation probe, a radio-frequency ablation probe, a pulsed field ablation probe, a pulsed electrical field ablation probe ablation, an irreversible electroporation ablation probe, a thermal ablation probe, an ultrasound ablation probe, a high- frequency ultrasound ablation probe, and a laser ablation probe.
15. The robotic system of claims 8-14, further comprising a sensor configured to determine a position and orientation of a distal end of the robotic articulating catheter.
